In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cerevast Medical Inc.

www.cerevast.com

Latest From Cerevast Medical Inc.

Pacts In Medtech: Glaukos To Distribute Saten's MicroShunt; Acell Signs Distribution Deals

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, R&D partnerships and commercial collaborations. This edition covers industry pacts that were signed in March and April 2019.

Pacts in Medtech Deals

Phase III Trial Of Cerevast’s Transcranial Ultrasound To Treat Stroke Misses Endpoint

The 90-day results of CLOTBUST ER, published in The Lancet, show sonothrombolysis to treat acute ischemic stroke is feasible and probably safe, but the trial did not show a clinical benefit of the therapy in conjunction with alteplase treatment.

Clinical Trials Commercial

Appointments: Astellas, BIO, Hikma, Eton, Akili and Oxford BioDynamics

This week's roundup includes CEO appointments by Eton Pharmaceuticals, the Biotechnology Innovation Organization and Hikma, in addition to various other high-level appointments by Astellas, Akili Interactive Labs and Oxford BioDynamics.

BioPharmaceutical Appointments

Cerevast Therapeutics’ Ultrasonic Stroke Treatment Gains Momentum

Cerevast Therapeutics is gaining momentum as the company raises new funds and advances enrollment in its pivotal Phase III clinical trial evaluating its Clotbust ER, an ultrasonic head-frame that delivers acoustic energy to the brain to enhance clot dissolution in acute ischemic stroke patients who receive intravenous tPA.

Medical Device Innovation
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
    • Rehabilitation Equipment and Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Cerevast Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cerevast Medical Inc.
  • Senior Management
  • Bradford A Zakes, Pres. & CEO
    Kendall Stever, CFO
    Francesco P Curra, PhD, CTO
  • Contact Info
  • Cerevast Medical Inc.
    Phone: (425) 748-7529
    12100 NE 195th St., Ste. 150
    Bothell, WA 98011
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register